Promoting Repigmentation After Epidermal Cell Suspension Grafting and preVENTing the Loss of Melanocytes Using Topical Ruxolitinib for Vitiligo in Resistant Areas
Clinical trial NCT05872477 · COMPLETED
Trial details
- NCT number
- NCT05872477
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-05
- Primary completion
- 2024-02-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.